Data for: Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin

The use of systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in appendiceal carcinomatosis is not associated with better clinical outcomes. Traditional agents may not be effective and other regimens are needed.